Prof. Dr. med. Georg Häcker
Group Leader
Telephone Lab: | +49 761 203 5363 |
---|---|
Telephone Secretary | +49 761 203 6532 |
Fax: | +49 761 203 6651 |
georg.haecker@uniklinik-freiburg.de |
CV
1983 | Qualification to enter university |
1990 | Medical Examination |
1991 | Doctoral degree (Dr. med., University of Ulm) |
1992 | Approbation (Licence to practise as a medical doctor) |
1993-1995 | Visiting Scientist, Walter and Eliza Hall Institute (Scholarship from the German Research Council, DFG) |
1995 | Research Officer, Walter and Eliza Hall Institute for Medical Research, Melbouren, Australia |
1998 | Habilitation (qualification to join faculty / teaching qualification) in Medical Microbiology and Immunology, Faculty for Medicine, Technical University Munich |
1998-2000 | Privatdozent, Institute for Medical Microbiology, TUM |
2000-2009 | Professor, Institute for Medical Microbiology, Immunology and Hygiene, TUM |
2002 | Specialist Examination (Medical Microbiology and Epidemiology of Infectious Diseases), (Bavarian College of Medical Doctors) |
07/2009 | Full professor and Chair, Department of Medical Microbiology and Hygiene, University of Freiburg, Germany |
Team
Name | Position | Telefon | |
---|---|---|---|
Prof. Georg Häcker | Head | 203- 6531 | georg.haecker@uniklinik-freiburg.de |
Dr. rer. nat. Arnim Weber | Postdoc | 203- 5362 | arnim.weber@uniklinik-freiburg.de |
Dr. rer.nat. Aladin Haimovici | Postdoc | 203- 6522 | aladin.haimovici@uniklinik-freiburg.de |
Dr. Collins Waguia Kontchou | Postdoc | 203- 5358 | collins.kontchou@uniklinik-freiburg.de |
Dr. Abdul Moeed | Postdoc | 203-6522 | abdul.moeed@uniklinik-freiburg.de |
Arlena Metz | BTA | 203- 5358 | arlena.metz@uniklinik-freiburg.de |
Julia Gregg | PhD student | 203- 5358 | julia.gregg@uniklinik-freiburg.de |
Tarek Amer | PhD sutdent | 203-5358 | tarek.amer@uniklinik-freiburg.de |
Infection
Human infection means that the body comes into contact with a pathogen. In most cases this contact is first with a cell that is not part of the professional immune system, such as an epithelial cell of a mucosal surface or a keratinocyte of the skin. These cells can recognize the pathogen and signal alert: the complex process of inflammation is initiated, and professional immune cells are recruited, especially neutrophil granulocytes. The activation of myeloid cells (granulocytes, macrophages, dendritic cells) is then required for the activation of the adaptive immune system, where lymphocytes (B cells, T cells) react and help clear the pathogen.
We are mostly working on trying to understand bacterial infection. Bacteria may all be small and look similar, but they are actually incredibly diverse. Even bacteria that live on humans can be as different as plants and animals. A bacterium causing purulent infection (such as Staphylococcus aureus) is very (very) different from the bacterium causing tuberculosis (Mycobacterium tuberculosis), and so on. Accordingly, while some general principles apply, the human body’s response to different bacteria can be very different, and many aspects of how bacteria infect and how human cells respond and fight the infection are still unclear.
Within this general theme, we work on the following areas (more detail is given under the links):
Apoptosis
Apoptosis is a form of cell death that occurs because the cell activates a specific signaling pathway, which kills it (it is in a way suicide). Apoptosis is a reaction to many stimuli, and apoptosis plays a role in infection. Some pathogens live inside human cells, and if the cell kills itself this may stop replication of the pathogen. Some bacteria have even evolved specific mechanisms that can prevent the infected cell killing itself. We find this interesting and are studying this interplay. In order to be able to study it we also analyze some of the basic questions of apoptosis, for instance how the release of apoptosis-inducing proteins from mitochondria is initiated. link
Sub-lethal apoptosis signalling
In many cases of infection there is actually little apoptosis induced. There is however an intriguing process initiated that we call sub-lethal apoptosis signalling: the same signalling pathway operates that also causes apoptosis but it is activated only a little. The cell therefore does not die but the same pathway, surprisingly, activates rather than kills the infected cell. When the apoptosis-apparatus signals at a sub-lethal level, infected epithelial cells produce cytokines (signalling proteins of the immune cells that can activate professional immune cells) and can even to a degree inhibit the growth of intracellular bacteria. Many aspects of this signalling process are at this stage not understood. link
Infections with Chlamydia
Chlamydia is an unusual bacterium: it can grow only inside a human cell. It grows inside a vacuole in the cytosol, has to avoid the cell’s defence systems and has to acquire nutrients and building blocks for its growth from the host cell. Chlamydia, most important Chlamydia trachomatis, is a frequent pathogen and causes severe eye infections (especially in Africa) as well as pelvic inflammation and infertility in women (worldwide). The life style of Chlamydia in the cell seems complicated but is very successful. We are trying to understand some of the mechanisms of how the bacteria interact with human epithelial cells in vitro. We are also using a mouse model to understand better what is happening during human infection with Chlamydia. link
Infections with Helicobacter
Helicobacter pylori is frequently found in the human stomach, and can (relatively rarely) cause ulcers and cancer. Many pathways are known through which Helicobacter interacts with human cells. We are looking at some new aspects of this interactions, hoping to understand more about how Helicobacter causes inflammation and also cancer. link
Myeloid cells
We are interested in the contribution that myeloid cells, especially neutrophils but also macrophages, make to the control of infections and to inflammation and tissue damage. We have, together with Susanne Kirschnek, set up a cell system where we can very nicely differentiate these cells from immortalised progenitor cells. This line of research is now mainly continued by the Kirschnek group. link
Publications
Center for Microbiology and Hygiene
Institute for Microbiology and Hygiene
Hermann-Herder-Str. 11
D-79104 Freiburg
E-Mail: georg.haecker@uniklinik-freiburg.de